Effectiveness of Dasatinib(Sprycel) in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study
Phase of Trial: Phase IV
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 08 Sep 2017 Status changed from active, no longer recruiting to completed.
- 09 Aug 2017 Planned End Date changed from 30 Jul 2017 to 15 Aug 2017.
- 09 Aug 2017 Planned primary completion date changed from 30 Jul 2017 to 15 Aug 2017.